We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
Campaigners in the US and Malta are protesting against laws that prevent doctors inducing abortion even in dangerous circumstances
More than two years into the pandemic, people have acquired different levels of immunity through infections and shots
Owning physical drugstores is not the cash cow it once was
New three-year contract in place if UK drugmaker continues to manufacture the jab
Some managers expect cheaper valuations will fuel M&A activity
Change would incorporate genetic material from fast-spreading strain in new boosters
The global south has once again been abandoned in its quest for vaccines
Owner of UK pharmacy and beauty group blames market turmoil for bids below its expectations
Remote providers report a leap in requests as conservative US states roll out a number of restrictions
Washington seeks to expand domestic production of crucial component of mRNA vaccines
Short break in immune suppression treatment improves antibody production after vaccination while doing little harm
UK social care provider has benefited from rising demand during the pandemic
New vaccine candidates significantly outperform existing Covid jabs at targeting the most prevalent strain
Providers of the procedure scramble as Republican-led states enact pre-planned bans while others consider their own moves
Companies offer to pay travel expenses for procedure but most refrain from taking sides
Governments need to plan now for what could be a tough autumn
Pharma companies are hoping to catch up with rivals as they report promising trial results for jab
Javid says he asked officials to revise previous plans that would exclude under-65s
Xi Jinping orders public health policy to prioritise Covid control over all other diseases
UK health agency investigating possibility of community transmission says risk to public ‘extremely low’
US biotech group says shot targeting both first strain and Omicron could help avert ‘large rise’ in cases
Government seeks to secure domestic jab supply and prepare for future pandemics in deal with Boston biotech
Early-stage drugmakers face difficult decisions as public markets turn hostile
This legal manoeuvre is setting a new precedent for corporations to evade accountability in America
After years in retreat, the disease is once again on the rise across the continent
UK Edition
